Biologic Imaging Reagents Market by Type, End-user, Technology - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

According to Nova one advisor, the global Biologic Imaging Reagents Market Size was valued at USD 18.3 billion in 2022 and is predicted to be worth USD 45.9 billion by 2032, with a CAGR of 11.9% from 2023 to 2032. 

Biologic Imaging Reagents Market: Introduction

• Biologic imaging reagents are substances utilized by researchers or by medical practitioners to conduct diagnostic or research based activities. Biologic imaging reagents play a significant role in the healthcare, biotechnological & life science sector. They provide significant assistance in the detection of biological processes at a molecular level.
• The biologic imaging reagents market can be segmented based on type, technology, end-user, and region. Based on type, the biologic imaging reagents market can be categorized into nuclear reagents, contrast reagents, optical reagents, and others. The contrast reagents segment can be further sub-segmented into MRI, optical imaging, X-ray & CT, ultrasound, nuclear, and others. Based on end user, the market can be categorized into research & academic institutes, diagnostic laboratories, life science companies, imaging centers, and others. Based on technology, the market can be split into fluorescent dyes & probes, fluorescent proteins, radiopharmaceuticals, quantum dots, and nanoparticles.

Report Scope of the Biologic Imaging Reagents Market

Key Drivers, Restraints, and Opportunities of Global Biologic Imaging Reagents Market

• Technological advances in biologic imaging reagents are occurring at a rapid pace. These technologies involve microfluidics, protein engineering, biologic targeting, nanotechnology, and supramolecular chemistry. Rapid development in technology has already transformed the biologic imaging industry by the formation of newer imaging reagents and offering significant opportunities. The higher growth rate witnessed by the biologic imaging reagents market has resulted in the adoption of customized medicine, which demands a molecular approach regarding the early diagnosis & monitoring of drugs. Similarly, the impact of continuous advancement in proteomics as well as in genomics are generating biomarkers of diseases. This source of biologic targets could be exploited by biologic imaging reagents for the diagnosis of early plaques formed in Alzheimer’s disease or the early detection of cancerous cells.
• The increasing pursuit of excellent technology for the diagnosis of multiple kind of ailments including nervous system, malignancy, heart blood vessel disorders and the increasing symptomatic imaging method, rising expenditure in analysis projects for updating the therapeutics and growing consciousness amidst the population with regards to the benefits of imaging technology are key factors that are projected to boost the biologic imaging reagents market during the forecast period. Meanwhile, the higher costs and funding requirements are estimated to hamper the market, while continuous enhancement in the diagnosis section of the same is likely to offer significant opportunity.

North America to Capture Major Share of Global Biologic Imaging Reagents Market

• North America dominated the global biologic imaging reagents market, in terms of share, due to the availability of complex healthcare infrastructure, patient awareness levels, and rise in high per capita healthcare expenditure. Furthermore, rapid adoption of numerous types of modalities by end-users, technological improvements, and an increase in cases of chronic diseases including cardiovascular disease and cancer in the region are attributed to the dominant share held by North America. Europe followed North America, in terms of share of the global biologic imaging reagents market owing to rising research and development activities in the region.
• However, the market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period owing to the presence of unmet medical needs and rising economic growth, which is assisting healthcare infrastructure enhancement in countries including India and China. Rise in lucrative opportunity for clinical and preclinical trials observational studies at lower costs and government support in research and development activities are further boosting the biologic imaging reagents market in the region.

Some of the prominent players in the Biologic Imaging Reagents Market include:

• Bracco Spa
• Lantheus Holdings, Inc.
• General Electric Company
• Siemens AG
• Bayer AG
• CMC Contrast AB
• Thermo Fisher Scientific Inc.
• Merck & Co., Inc.
• Shimadzu Corporation
• Koninklijke Philips N.V.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Biologic Imaging Reagents market.

Global Biologic Imaging Reagents Market, by Type

• Nuclear Reagents
• Contrast Reagents
• MRI
• Optical Imaging
• X-ray & CT
• Ultrasound
• Nuclear
• Others
• Optical Reagents
• Others

Global Biologic Imaging Reagents Market, by End-user

• Research & Academic Institutes
• Diagnostic Laboratories
• Life Science Companies
• Imaging Centers
• Others

Global Biologic Imaging Reagents Market, by Technology

• Fluorescent Dyes & Probes
• Fluorescent Proteins
• Radiopharmaceuticals
• Quantum Dots
• Nanoparticles

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Biologic Imaging Reagents industry analysis from 2023 to 2032 to identify the prevailing Biologic Imaging Reagents industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Biologic Imaging Reagents industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Biologic Imaging Reagents industry trends, key players, market segments, application areas, and market growth strategies.